Profile data is unavailable for this security.
About the company
Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.
- Revenue in USD (TTM)2.91bn
- Net income in USD-102.27m
- LocationEndo International PLCMinerva House, Simmonscourt RoadDUBLIN 000 00IrelandIRL
- Phone+353 12682000
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|ENDP:NSQ since |
|BioSpecifics Technologies Corp||Announced||19 Oct 2020||19 Oct 2020Announced||2.01%||700.16m|